Back
Nuveen Taxable Municipal Income Fund Vs. Axsome Therapeutics, Inc. Industry Stock Comparison
Sell
11
NBB
Nuveen Taxable Municipal Income Fund
Last Price:
$15.80
Seasonality Move:
0.25%
Buy
75
AXSM
Axsome Therapeutics, Inc.
Last Price:
$182.74
Seasonality Move:
22.61%
Sell
11
Nuveen Taxable Municipal Income Fund (NBB)
is a Sell
Is Nuveen Taxable Municipal Income Fund a Buy, Sell or Hold?
-
The current Nuveen Taxable Municipal Income Fund [NBB] share price is $15.80. The Score for NBB is 11, which is 78% below its historic median score of 50, and infers higher risk than normal.
-
NBB is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
75
Axsome Therapeutics, Inc. (AXSM)
is a Buy
Is Axsome Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Axsome Therapeutics, Inc. [AXSM] share price is $182.64. The Score for AXSM is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
-
AXSM is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
NBB Stock Price Chart
What is Nuveen Taxable Municipal Income Fund's stock price today?
-
The Nuveen Taxable Municipal Income Fund share price today is $15.80Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBB is experiencing selling pressure, which indicates risk of future bearish movement.
AXSM Stock Price Chart
What is Axsome Therapeutics, Inc.'s stock price today?
-
The Axsome Therapeutics, Inc. share price today is $182.64Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AXSM is experiencing buying pressure, which is a positive indicator for future bullish movement.
NBB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.11 | Sell |
| Relative Strength Index (14 RSI): | 40.39 | Sell |
| Chaikin Money Flow: | -96098 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (15.86 - 16.2) | Sell |
| Bollinger Bands (100): | (15.89 - 16.35) | Sell |
AXSM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.73 | Buy |
| Relative Strength Index (14 RSI): | 79.74 | Buy |
| Chaikin Money Flow: | 2638953 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (143.49 - 157.75) | Buy |
| Bollinger Bands (100): | (116.98 - 146.48) | Buy |
NBB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 15.82 | Sell |
| 20-day SMA: | 15.99 | Sell |
| 50-day SMA: | 16.18 | Sell |
| 200-day SMA: | 15.84 | Sell |
| 8-day EMA: | 15.86 | Sell |
| 20-day EMA: | 15.96 | Sell |
| 50-day EMA: | 16.07 | Sell |
| 200-day EMA: | 15.97 | Sell |
AXSM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 156.17 | Buy |
| 20-day SMA: | 151.07 | Buy |
| 50-day SMA: | 144.32 | Buy |
| 200-day SMA: | 119.69 | Buy |
| 8-day EMA: | 157.9 | Buy |
| 20-day EMA: | 152.42 | Buy |
| 50-day EMA: | 144.44 | Buy |
| 200-day EMA: | 123.72 | Buy |
Nuveen Taxable Municipal Income Fund Earnings Growth & NBB Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Axsome Therapeutics, Inc. Earnings Growth & AXSM Earnings Dates
-
Analysts estimate an earnings increase this quarter of $1.25 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.11 per share, and an increase next year of $5.92 per share.
Nuveen Taxable Municipal Income Fund Technical Analysis
| Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 16 | 17 | 18 | 19 | 22 | 24 | 26 | 29 | 30 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Axsome Therapeutics, Inc. Technical Analysis
| Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | 30 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||